AtriCure, Inc. (ATRC)
Healthcare • Medical Instruments & Supplies
StockNasdaqGMUnited StatesUS04963C2098
56.77 USD
+1.41% today Updated 13 Nov 2026 14:52
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by AtriCure, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 14:52. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
16 Feb 2027
in 95 days · 16:00 · estimate 0.07
Last results
0.17 vs 0.01 estimated
03 Nov 2026 · Beat +1,326.2%
Beat the estimate
10 of 12
1 missed · 1 in line · 8 beats in a row
Average surprise
+211.5%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 16 Feb 2027 16:00 | 0.07 | — | — | Upcoming |
| 03 Nov 2026 16:00 | 0.01 | 0.17 | +1,326.2% | Beat |
| 23 Jul 2026 16:00 | 0.02 | 0.18 | +650.3% | Beat |
| 05 May 2026 16:00 | -0.06 | — | +100.0% | — |
| 17 Feb 2026 16:00 | -0.04 | 0.06 | +249.9% | Beat |
| 29 Oct 2025 16:00 | -0.12 | -0.01 | +91.5% | Beat |
| 29 Jul 2025 16:00 | -0.16 | -0.02 | +87.7% | Beat |
| 29 Apr 2025 16:00 | -0.22 | -0.14 | +37.3% | Beat |
| 12 Feb 2025 16:00 | -0.15 | -0.08 | +46.2% | Beat |
| 29 Oct 2024 16:00 | -0.20 | -0.17 | +13.4% | Beat |
| 30 Jul 2024 16:00 | -0.17 | -0.17 | +0.2% | In line |
| 01 May 2024 16:00 | -0.23 | -0.25 | -8.3% | Miss |
| 15 Feb 2024 16:00 | -0.23 | -0.21 | +8.0% | Beat |
| 01 Nov 2023 16:00 | -0.31 | -0.20 | +35.7% | Beat |
| 25 Jul 2023 16:00 | -0.31 | -0.12 | +61.6% | Beat |
| 02 May 2023 16:00 | -0.35 | -0.23 | +34.3% | Beat |
| 21 Feb 2023 16:00 | -0.18 | -0.09 | +49.5% | Beat |
| 01 Nov 2022 16:00 | -0.25 | -0.27 | -5.9% | Miss |
| 02 Aug 2022 16:00 | -0.29 | -0.32 | -10.9% | Miss |
| 03 May 2022 16:00 | -0.34 | -0.33 | +4.0% | Beat |
| 15 Feb 2022 16:00 | -0.31 | -0.30 | +2.5% | Beat |
| 03 Nov 2021 16:00 | -0.29 | -0.23 | +19.7% | Beat |
| 04 Aug 2021 16:00 | -0.30 | -0.30 | +1.5% | Beat |
| 27 Apr 2021 16:00 | -0.36 | -0.32 | +10.9% | Beat |
| 23 Feb 2021 16:00 | -0.25 | -0.18 | +28.3% | Beat |
| 05 Nov 2020 16:00 | -0.31 | -0.11 | +64.1% | Beat |
| 28 Jul 2020 16:00 | -0.54 | -0.38 | +29.0% | Beat |
| 29 Apr 2020 17:00 | -0.40 | -0.36 | +10.6% | Beat |
| 18 Feb 2020 16:00 | -0.40 | -0.37 | +6.8% | Beat |
| 30 Oct 2019 16:00 | -0.31 | -0.33 | -7.5% | Miss |
| 30 Jul 2019 16:00 | -0.17 | -0.17 | +1.7% | Beat |
| 25 Apr 2019 16:00 | -0.24 | -0.20 | +17.8% | Beat |
| 28 Feb 2019 16:00 | -0.16 | -0.21 | -31.3% | Miss |
| 01 Nov 2018 16:00 | -0.21 | -0.24 | -14.3% | Miss |
| 01 Aug 2018 16:00 | -0.22 | -0.19 | +15.6% | Beat |
| 26 Apr 2018 16:00 | -0.27 | -0.31 | -15.5% | Miss |
| 26 Feb 2018 16:00 | -0.21 | -0.08 | +62.4% | Beat |
| 01 Nov 2017 16:00 | -0.24 | -0.22 | +8.3% | Beat |
| 27 Jul 2017 16:00 | -0.26 | -0.21 | +20.1% | Beat |
| 04 May 2017 16:00 | -0.36 | -0.32 | +9.9% | Beat |
| 28 Feb 2017 16:00 | -0.32 | -0.27 | +15.5% | Beat |
| 27 Oct 2016 16:00 | -0.28 | -0.21 | +24.9% | Beat |
| 04 Aug 2016 16:00 | -0.30 | -0.26 | +14.0% | Beat |
| 28 Apr 2016 16:00 | -0.32 | -0.31 | +4.0% | Beat |
| 23 Feb 2016 16:00 | -0.34 | -0.36 | -5.9% | Miss |
| 27 Oct 2015 16:00 | -0.22 | -0.22 | +0.7% | In line |
| 28 Jul 2015 16:00 | -0.21 | -0.18 | +15.9% | Beat |
| 29 Apr 2015 16:00 | -0.21 | -0.19 | +8.8% | Beat |
| 23 Feb 2015 16:00 | -0.20 | -0.20 | -1.0% | Miss |
| 30 Oct 2014 16:00 | -0.18 | -0.02 | +88.9% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 534.5M | +14.9% | — | — | -0.24 | +74.7% | 42.3M |
| 2024 | 465.3M | +16.5% | -44.7M | -9.6% | -0.95 | -43.9% | -11.3M |
| 2023 | 399.2M | +20.8% | -30.4M | -7.6% | -0.66 | +35.3% | -37.5M |
| 2022 | 330.4M | — | -46.5M | -14.1% | -1.02 | — | -39M |
| 2021 | — | — | 50.2M | — | — | — | — |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 13 Nov 2026 In progress | 58.62 | 59.85 | 54.74 | 56.01 | -4.32% | 3,061,487 | |
| 02 Nov 2026 – 06 Nov 2026 | 61.70 | 66.02 | 58.00 | 58.54 | -4.42% | 5,659,600 | |
| 26 Oct 2026 – 30 Oct 2026 | 59.35 | 63.00 | 58.85 | 61.25 | +3.87% | 3,915,200 | |
| 19 Oct 2026 – 23 Oct 2026 | 55.75 | 59.56 | 55.16 | 58.97 | +5.17% | 2,615,200 | |
| 12 Oct 2026 – 16 Oct 2026 | 56.29 | 58.44 | 55.67 | 56.07 | +0.47% | 3,540,200 | |
| 05 Oct 2026 – 09 Oct 2026 | 54.14 | 56.60 | 51.63 | 55.81 | +1.22% | 4,020,800 | |
| 28 Sep 2026 – 02 Oct 2026 | 57.56 | 59.05 | 52.00 | 55.14 | -5.55% | 6,735,700 | |
| 21 Sep 2026 – 25 Sep 2026 | 58.23 | 61.70 | 56.97 | 58.38 | +0.48% | 6,013,600 | |
| 14 Sep 2026 – 18 Sep 2026 | 54.84 | 59.88 | 54.65 | 58.10 | +6.53% | 14,013,800 | |
| 08 Sep 2026 – 11 Sep 2026 | 54.31 | 55.72 | 51.74 | 54.54 | +5.86% | 5,600,500 | |
| 252 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- AtriCure, Inc. (ATRC) Presents at 2026 UBS Global Healthcare Conference Transcript (opens in a new tab) SeekingAlpha · 09 Nov 2026 14:01
- AtriCure: A New Quality Metric Could Put A Clip In Nearly Every Sternotomy (opens in a new tab) SeekingAlpha · 08 Nov 2026 00:16
- Is AtriCure (ATRC) Fully Valued After Strong Results And Raised 2026 Guidance? (opens in a new tab) Simply Wall St. · 05 Nov 2026 16:20
- Canaccord Genuity Maintains Buy on AtriCure, Raises Price Target to $67 (opens in a new tab) Benzinga · 04 Nov 2026 19:33
- AtriCure (ATRC) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 04 Nov 2026 15:29
- Piper Sandler Reiterates Overweight on AtriCure, Raises Price Target to $70 (opens in a new tab) Benzinga · 04 Nov 2026 13:20
- AtriCure Analysts Boost Their Forecasts After Better-Than-Expected Q3 Results (opens in a new tab) Benzinga · 04 Nov 2026 06:36
- Needham Maintains Buy on AtriCure, Raises Price Target to $70 (opens in a new tab) Benzinga · 04 Nov 2026 06:18
- BTIG Maintains Buy on AtriCure, Raises Price Target to $70 (opens in a new tab) Benzinga · 04 Nov 2026 06:04
- AtriCure, Inc. (ATRC) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 04 Nov 2026 02:15
- What AtriCure (ATRC) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 04 Nov 2026 00:14
- AtriCure (NASDAQ:ATRC) Q3 2026 Earnings: EPS Beat, Revenue Inline, Soft Guidance Weighs on Shares (opens in a new tab) ChartMill · 03 Nov 2026 23:12
- Compared to Estimates, AtriCure (ATRC) Q3 Earnings: A Look at Key Metrics (opens in a new tab) Zacks · 03 Nov 2026 21:30
- AtriCure (ATRC) Beats Q3 Earnings and Revenue Estimates (opens in a new tab) Zacks · 03 Nov 2026 21:10
- AtriCure: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 03 Nov 2026 21:07
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 55.98 USD
- Market cap
- 2.9B
- Exchange
- NasdaqGM
- Country
- United States
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow ATRC and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.